Stefan Aigner

Stefan Aigner appears in our data through filings on Alpharma Inc shares, published by SEC (Form 4). In total, 20 filings cover trades dated from 1 March 2007 to 22 August 2008.

In open-market terms, that means 8 purchases worth €259k on one side and 4 sales worth €371k on the other. Sales outweigh purchases by €112k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 8 share grants. 2008 to date brings 7 purchases and 4 sales.

Half of the purchases are above €13k and half below.

The record was last updated on 26 August 2008 with an open-market sale (€247k) in Alpharma Inc. The clock since the last published purchase (5 March 2008) now reads 6,806 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.